Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐obese diabetic mice

Aims/Introduction:  The therapeutic effectiveness against type 1 diabetes mellitus of a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, was examined in the non‐obese diabetic (NOD) mouse model. Materials and Methods:  Female NOD mice t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Takumi, Yoshida, Yuya, Fujita, Tetsuro, Kohno, Takeyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019244/
https://www.ncbi.nlm.nih.gov/pubmed/24843604
http://dx.doi.org/10.1111/j.2040-1124.2012.00218.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019244/
https://www.ncbi.nlm.nih.gov/pubmed/24843604
http://dx.doi.org/10.1111/j.2040-1124.2012.00218.x

Ejemplares similares